newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra
PSU Mantra

South Eastern Coalfields Ltd Plans to Develop Solar Power Projects of 600 MW

South Eastern Coalfields

South Eastern Coalfields Ltd (SECL) will be developing rooftop and ground mounted solar power projects of 600 MW capacity in the coming years as part of the company’s strategy to expand and diversify its business and achieve the “Net Zero Energy” goal. SECL, is planning to develop the above projects at a cost of more than Rs.1000 crores.Some of these projects would be implemented in RESCO (Renewable Energy Service Company)/BOO (Build-Own-Operate) mode.
Solar power projects of more than 180 MW are already in various phases of development in the operational areas of SECL spread over Chhattisgarh and Madhya Pradesh. It has recently commissioned rooftop solar projects of 580 kWp capacity in Johilla, Jamuna-Kotma and Kusmunda Areas.
At Johilla Area, the commissioned capacity is about 280 kWp which is the highest capacity rooftop solar project in the entire company.  Solar panels have been installed at Administrative Building GM office, SECL-run Kendriya Vidyalaya, Regional Hospital and at Area’s Guesthouse. The project will generate about 4,20,000 units of electricity  saving about Rs 21 lakh annually in power expenditure.
The largest two solar projects under implementation are of 40 MW capacity each. A 40 MW ground mounted, grid connected solar PV plant is being developed on company’s own land in Bhatgaon and Bishrampur areas located in Chattisgarh’s Surajpur district. The project is at execution stage and likely to be commissioned during this fiscal.
The management is also working on a project report for installation of another 40 MW ground mounted solar PV plant in Johilla area in Madhya Pradesh.

Related posts

CMD, IREDA Emphasizes Role of Renewables in Achieving Net Zero Target

Newsmantra

SECL will supply 28.24 lakh tonnes of coal annually to NTPC Khargone

Newsmantra

Zydus receives USFDA approval for ZITUVIMET TM to treat adult patients with type 2 diabetes mellitus

Newsmantra

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More